MSOS News

February MSOS Member Briefing Webinar
Post date: 3 years 9 months ago

Sign up now for the next quarterly MSOS Member Briefings webinar scheduled to be held on Thursday, February 22, 2018 from 1:00-2:00 pm EST. Topics will include:

  • Expanding the Use of Capnography to Monitor High Risk Opioid Patients
    • Safe Use of EPINEPhrine
  • Meeting the New ISMP Best Practice: Eliminating Injectable Promethazine
  • ISMP update.

This free webinar has limited attendance and is restricted to MSOS members. For registration information, go to: https://register.gotowebinar.com/register/3875384151275245570

Two February Dates You Don't Want to Miss
Post date: 3 years 9 months ago

High Alert Self Assessment Deadline: February 28, 2018

Healthcare facilities that would like to participate in the first ISMP Medication Safety Self Assessment for High-Alert Medications must submit their data by February 28, 2018. This is a unique opportunity to evaluate your best practices related to high-alert medications and obtain weighted scores to compare with demographically similar organizations. Participation can also help meet requirements for managing high-alert medications from regulatory and accrediting agencies. To access the self assessment workbook, go to: www.ismp.org/selfassessments/SAHAM/Default.aspx

Don't Miss February Just Culture Certification Course  

Time is running out to register for Outcome Engenuity (OE) and ISMP's Medication Safety Focused Just Culture Certification Course, being offered February 21-22 in Phoenix, AZ. Learn how to lead your organization through a culture transformation, which is essential for effective error prevention, and receive a subscription to the Just Culture Assessment Tool. Sign up with  ISMP's discount code (ISMP2018) to receive $200 off registration. For more information, visit: www.ismp.org/sc?id=3040.

Have you eliminated injectable promethazine?
Post date: 3 years 10 months ago

ISMP is looking for organizations that have fully implemented the new ISMP Targeted Medication Safety Best Practices for Hospitals #13 (below).  If you are able to share your experience(s), please contact Allen Vaida at avaida@ismp.org. 

#13- Eliminate injectable promethazine from the hospital.

  • Remove injectable promethazine from all areas of the hospital including the pharmacy.
  • Classify injectable promethazine as a non-stocked, non-formulary medication.
  • Implement a medical staff-approved automatic therapeutic substitution policy to convert all injectable promethazine orders to another antiemetic.
  • Remove injectable promethazine from all computerized medication order screens, and from all order sets and protocols.
Next MSOS Member Briefings
Post date: 3 years 10 months ago

Mark your calendars for the next MSOS Member Briefings webinar, to be held on Thursday, February 22, 2018 from 1:00-2:00pm EST.  More information regarding topics and registration will be sent later this month.

If you have implemented a “high leverage” solution to a specific medication safety issue that you would like to share with the MSOS members on an upcoming Briefings webinar, please contact E. Robert Feroli at bob@jhmi.edu. Be sure to include a brief description of the 10-minute presentation topic.  

ISMP Releases 2018-2019 Targeted Medication Safety Best Practices
Post date: 3 years 10 months ago

This week ISMP has launched an updated version of its Targeted Medication Safety Best Practices, which include two revised and three new  practices for 2018-19.

To download a copy, go to: http://www.ismp.org/tools/bestpractices/default.aspx.

The purpose of the Targeted Medication Safety Best Practices for Hospitals is to identify, inspire, and mobilize widespread, national adoption of consensus-based best practices for specific medication safety issues that continue to cause fatal and harmful errors in patients, despite repeated warnings in ISMP publications.

Pages

read more...